Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
NCT ID: NCT07000019
Last Updated: 2025-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
28 participants
INTERVENTIONAL
2025-06-30
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To determine the extent to which this combined treatment can improve language.
* To determine the extent to which the combined treatment can improve arm movements.
Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combined aphasia and robot-assisted arm treatment
CARAT: combined aphasia and robot-assisted arm therapy
Participants will receive 18 sessions of robot-assisted arm therapy combined with a standardized picture-word verification therapy task with the goal of improving language and arm movements.
Robot-assisted arm treatment
Robot-assisted arm therapy
Participants will receive 18 sessions of robot-assisted arm therapy with the goal of improving arm movements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CARAT: combined aphasia and robot-assisted arm therapy
Participants will receive 18 sessions of robot-assisted arm therapy combined with a standardized picture-word verification therapy task with the goal of improving language and arm movements.
Robot-assisted arm therapy
Participants will receive 18 sessions of robot-assisted arm therapy with the goal of improving arm movements.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Right-handed prior to stroke
3. English-speaking (monolingual)
4. History of single left-hemisphere stroke at least 6 months prior to enrollment
5. Presence of aphasia and naming deficits on Western Aphasia Battery (WAB-R)
6. Comprehension score above 4 on WAB-R
7. Unilateral upper limb paresis (Fugl-Meyer Upper Extremity score \<56)
8. Documentation of signed Informed Consent by the study participant.
Exclusion Criteria
2. Severely limited speech output (score below 2 on spontaneous speech portion of WAB-R)
3. Inability to perform screening tasks due to severe language and/or cognitive impairment
4. Condition limiting passive movement in the range of motion required for robotic therapy (e.g. fixed contracture)
5. Any medical or psychiatric condition that may impact participation or compliance with study procedures or activities in the opinion of the investigator
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Medical College
OTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
New York University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tomoko Kitago, MD
Assistant Professor of Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomoko Kitago, MD
Role: PRINCIPAL_INVESTIGATOR
Westchester Medical Center / New York Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westchester Medical Center / New York Medical College
Valhalla, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Cristina Falo, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NYMC-25470
Identifier Type: -
Identifier Source: org_study_id